Congenital heart diseaseSafety and Results of Cryoablation in Patients <5 Years Old and/or <15 Kilograms
Section snippets
Methods
The present study was an international multicenter retrospective review of cryoablation in infants and children <5 years old and/or weighing <15 kg at the ablation procedure, including those in whom cryoablation was unsuccessful and RF was then used. Members of the Pediatric and Congenital Electrophysiology Society retrospectively collected data from the existing patient records at each of their respective institutions. The data were submitted to the primary investigators for analysis. All
Results
Eleven centers participated, contributing data on a total of 68 procedures performed on 61 patients. The diagnosis at initial presentation is listed in Table 1. Congenital heart disease was present in 14 (23%) of the 61 patients. Of the 61 patients, 4 had undergone a previous heart operation (3 atriotomies and 1 ventriculotomy). A total of 10 patients (16%) had signs of congestive heart failure before the ablation procedure—8 of these were in incessant tachycardia (5 with PJRT and 3 with focal
Discussion
The present study revealed several important findings. First, the use of cryoablation in this young, small patient population resulted in no major complications. Second, major complications occurred when small or young patients intended to be treated with cryoablation are converted to treatment with RF energy. Finally, surveillance for coronary artery damage in these patients was not routine and the risk of coronary artery injury was not assessable.
In the present study, no major complications
Acknowledgment
Thank you to Lacey Henry, Children's Hospital Denver, Nancy Chiesa, RN, UCSF Children's Hospital, and Mary Sokoloski, MD, Holtz Children's Hospital, for your assistance in data collection.
References (23)
- et al.
Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults
Heart Rhythm
(2006) - et al.
Long-term outcomes for cryoablation of pediatric patients with atrioventricular nodal reentrant tachycardia
Am J Cardiol
(2010) - et al.
Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety
Heart Rhythm
(2007) - et al.
Coronary artery involvement early and late after radiofrequency current application in young pigs
Am Heart J
(1997) - et al.
Incidence of coronary artery injury immediately after catheter ablation for supraventricular tachycardias in infants and children
Heart Rhythm
(2009) - et al.
Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants
Am Heart J
(2001) - et al.
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age
J Am Coll Cardiol
(2002) - et al.
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants
Am Heart J
(1996) - et al.
Radiofrequency catheter ablation in children with and without congenital heart disease: Report of the writing committeeNorth American Society of Pacing and Electrophysiology
Pacing Clin Electrophysiol
(2002) - et al.
Cryoablation of typical atrioventricular nodal reentrant tachycardia in children: six years' experience and follow-up in a single center
Pacing Clin Electrophysiol
(2010)
Successful transcatheter cryoablation in infants with drug-resistant supraventricular tachycardia: a case series
J Interv Card Electrophysiol
Cited by (22)
Ablation in Pediatric Patients and in Association with Congenital Heart Disease
2020, Cardiac Electrophysiology ClinicsSpecial Considerations for Ablation in Pediatric Patients
2019, Catheter Ablation of Cardiac ArrhythmiasPACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS)Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC)
2016, Heart RhythmCitation Excerpt :The most common reasons reported for avoiding cryoablation were high recurrence rates, poor catheter handling, and no personally experienced complications with RF-induced AV block. Nonetheless, the literature supports an exceptionally high safety profile using cryoablation, with no reports of AV block,231 even in small children217 or in the presence of a His potential.232 Thus, cryoablation has been generally recognized as a safer alternative to RF ablation in proximity to the normal conduction system, a feature that has made the technology particularly desirable in the pediatric population, in whom a complication can lead to a lifetime of morbidity, since most children with SVT are otherwise well.
AVNRT cryoablation in children <26 kg: efficacy and safety of electrophysiologically guided low-voltage bridge strategy
2023, PACE - Pacing and Clinical ElectrophysiologyPediatric Electrophysiology Device Needs: A Survey from the Pediatric and Congenital Electrophysiology Society Taskforce on Pediatric-Specific Devices
2022, Journal of the American Heart AssociationTechnical refinements for catheter ablation in young/small children
2021, Catheter Ablation of Cardiac Arrhythmias in Children and Patients with Congenital Heart Disease